Results 291 to 300 of about 416,036 (340)

A Novel Approach for Cisplatin-Resistant Esophageal Squamous Cell Carcinoma via Amino Acid Transporter LAT1 Inhibition. [PDF]

open access: yesCancer Med
Mozumi T   +16 more
europepmc   +1 more source

Isoform Specificity of a Compound Targeting Actin Filaments Containing Tropomyosin Tpm1.8/1.9

open access: yesCytoskeleton, EarlyView.
ABSTRACT The unbranched actin filaments in mammalian cells are usually composed of co‐polymers of a specific tropomyosin isoform with actin. Genetic manipulation has revealed that the tropomyosins largely define the functional properties of actin filaments in an isoform‐specific, non‐redundant manner.
Jeff Hook   +2 more
wiley   +1 more source

Determination of a New Biomarker at the Level of Gene Alteration in Cisplatin Ototoxicity. [PDF]

open access: yesInt J Mol Sci
Kızmazoğlu D   +7 more
europepmc   +1 more source

Monitoring Apoptotic Activity of Silver(I) Metallodrugs Containing Mefenamic Acid and Mitochondriotropic Agents in Artificial Breast Tumor Tissues

open access: yesChemMedChem, EarlyView.
MCF‐7 cancer cell cultures in 2D and 3D systems before and after 48 h of treatment with silver complexes of mefenamic acid. The results highlight the biological effectiveness of these compounds in advanced cellular models. The anticancer potential of silver(I) metallodrugs incorporating mefenamic acid and mitochondriotropic agents in 3D spheroid models
Christina N. Banti   +1 more
wiley   +1 more source

Recent Advances of In Situ Anticancer Nanomedicine from Enzyme‐Instructed Self‐Assembly

open access: yesChemNanoMat, EarlyView.
This review summarizes advances in enzymatic self‐assemblies for generating in situ anticancer nanomedicine over the past five years. It highlights the unique features of enzyme substrates for in situ anticancer nanomedicine by discussing the representative examples.
Linrui Zou, Meihui Yi, Bing Xu
wiley   +1 more source

The KLF4/Galectin-3 cascade is a key determinant of tubular cell death and acute kidney injury. [PDF]

open access: yesInt J Biol Sci
Liu L   +18 more
europepmc   +1 more source

Biomarkers for Early Detection of Cisplatin-Induced Nephrotoxicity. [PDF]

open access: yesLife (Basel)
Dimov N   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy